［1］ KADKOL SS,BRODY JR,EPSTEIN J I,et al. Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancer ［J］. Prostate,1998,34(3):231-237.
［2］ MUTAI H,TOYOSHIMA Y,SUN W,et al. PAL31,a novel nuclear protein,expressed in the developing brain ［J］. Biochemical and Biophysical Research Communications,2000,274(2):427-433.
［3］ PAN W,DA GRACA LS,SHAO Y,et al. PHAPI/pp32 suppresses tumorigenesis by stimulating apoptosis ［J］. J Biol Chem,2009,284(11):6946-6954.
［4］ KHAN MZ,VAIDYA A,MEUCCI O. CXCL12-mediated regulation of ANP32A/Lanp,a component of the inhibitor of histone acetyl transferase (INHAT) complex,in cortical neurons ［J］. J Neuroimmune Pharmacol,2011,6(1):163-170.
［5］ REILLY PT,YU Y,HAMICHE A,et al. Cracking the ANP32 whips:important functions,unequal requirement,and hints at disease implications ［J］. Bioessays,2014,36(11):1062-1071.
［6］SEO SB,MCNAMARA P,HEO S,et al. Regulation of histone acetylation and transcription by INHAT,a human cellular complex containing the set oncoprotein ［J］. Cell,2001,104(1):119-130.
［7］ TOCHIO N,UMEHARA T,MUNEMASA Y,et al. Solution structure of histone chaperone ANP32B:Interaction with core histones H3-H4 through its acidic concave domain ［J］. J Mol Biol,2010,401(1):97-114.
［8］ OBRI A,OUARARHNI K,PAPIN C,et al. ANP32E is a histone chaperone that removes H2A.Z from chromatin ［J］. Nature,2014,505(7485):648-653.
［9］ KATAYOSE Y,LI M,AL-MURRANI SW,et al. Protein phosphatase 2A inhibitors,I(1)(PP2A) and I(2)(PP2A),associate with and modify the substrate specificity of protein phosphatase 1 ［J］. J Biol Chem,2000,275(13):9209-9214.
［10］ HABRUKOWICH C,HAN DK,LE A,et al. Sphingosine interaction with acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) regulates PP2A activity and cyclooxygenase (COX)-2 expression in human endothelial cells ［J］. J Biol Chem,2010,285(35):26825-26831.
［11］ MOORE MJ,ROSBASH M. Cell biology. TAPping into mRNA export ［J］. Science,2001,294(5548):1841-1842.
［12］ FRIES B,HEUKESHOVEN J,HAUBER I,et al. Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression ［J］. J Biol Chem,2007,282(7):4504-4515.
［13］ KIM HE,JIANG X,DU F,et al. PHAPI,CAS,and Hsp70 promote apoptosome formation by preventing Apaf-1 aggregation and enhancing nucleotide exchange on Apaf-1 ［J］. Mol Cell,2008,30(2):239-247.
［14］ HOFFARTH S,ZITZER A,WIEWRODT R,et al. pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer ［J］. Cell Death Differ,2008,15(1):161-170.
［15］ SHEN SM,YU Y,WU YL,et al. Downregulation of ANP32B,a novel substrate of caspase-3,enhances caspase-3 activation and apoptosis induction in myeloid leukemic cells ［J］. Carcinogenesis,2010,31(3):419-426.
［16］ MATILLA A,RADRIZZANI M. The Anp32 family of proteins containing leucine-rich repeats ［J］. Cerebellum,2005,4(1):7-18.
［17］ LEO VI,BUNTE RM,REILLY PT. BALB/c-congenic ANP32B-deficient mice reveal a modifying locus that determines viability ［J］. Exp Anim,2016,65(1):53-62.
［18］ VAESEN M,BARNIKOL-WATANABE S,GOTZ H,et al. Purification and characterization of two putative HLA class II associated proteins:PHAPI and PHAPII ［J］. Biol Chem Hoppe Seyler,1994,375(2):113-126.
［19］ JIANG X,KIM HE,SHU H,et al. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway ［J］. Science,2003,299(5604):223-226.
［20］ SUN W,KIMURA H,HATTORI N,et al. Proliferation related acidic leucine-rich protein PAL31 functions as a caspase-3 inhibitor ［J］. Biochem Biophys Res Commun,2006,342(3):817-823.
［21］ SUN W,HATTORI N,MUTAI H,et al. PAL31,a nuclear protein required for progression to the S phase ［J］. Biochem Biophys Res Commun,2001,280(4):1048-1054.
［22］ YU Y,SHEN SM,ZHANG FF,et al. Acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B) contributes to retinoic acid-induced differentiation of leukemic cells ［J］. Biochem Biophys Res Commun,2012,423(4):721-725.
［23］ LI CX,SHEN SM,WANG LS,et al. Caspase-3-resistant uncleavable form of acidic leucine-rich nuclear phosphoprotein 32B potentiates leukemic cell apoptosis ［J］. Mol Med Rep,2015,11(4):2813-1288.
［24］ OHNO Y,KOIZUMI M,NAKAYAMA H,et al. Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma ［J］. PLoS One,2017,12(5):e0177343.
［25］ 朱迪,朱晓娜,杨烁,等. 酸性亮氨酸核磷酸蛋白32B在肝癌组织表达增强并促进肝癌细胞生长的研究［J］. 诊断学理论与实践,2019,18(02):170-176.
ZHU D,ZHU XN,YANG S,et al. Study on ANP32B expression in hepatocellular carcinoma and its significance［J］. Journal of Diagnostics Concepts & Practice,2019,18(02):170-176.
［26］ 朱迪. ANP32B在肝癌发生发展中的作用研究［D］. 上海：上海交通大学,2019.
ZHU D. The Roles of ANP32B in the development of hepatocellular carcinoma［D］. Shanghai：Shanghai Jiao Tong University,2019.
［27］ REILLY PT,AFZAL S,GORRINI C,et al. Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian development ［J］. Proc Natl Acad Sci USA,2011,108(25):10243-10248.
［28］ YANG S,ZHOU L,REILLY PT,et al. ANP32B deficiency impairs proliferation and suppresses tumor progression by regulating AKT phosphorylation ［J］. Cell Death Dis,2016,7(2):e2082.
［29］ D'ANGELO A,SOBHANI N,ROVIELLO G,et al. Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma ［J］. PLoS One,2019,14(8):e0219566.
［30］ UZOZIE AC,SELEVSEK N,WAHLANDER A,et al. Targeted proteomics for multiplexed verification of markers of colorectal tumorigenesis ［J］. Mol Cell Proteomics,2017,16(3):407-427.
［31］ SNEZHKINA AV,LUKYANOVA EN,FEDOROVA MS,et al. Novel genes associated with the development of carotid paragangliomas［J］. Mol Biol (Mosk),2019,53(4):613-626.
［32］ DICKINSON A,SARASWAT M,MAKITIE A,et al. Label-free tissue proteomics can classify oral squamous cell carcinoma from healthy tissue in a stage-specific manner ［J］. Oral Oncol,2018,86:206-215.
［33］ MUNEMASA Y,SUZUKI T,AIZAWA K,et al. Promoter region-specific histone incorporation by the novel histone chaperone ANP32B and DNA-binding factor KLF5 ［J］. Mol Cell Biol,2008,28(3):1171-1181.
［34］ VAN DER FELTZ C,HOSKINS AA. Structural and functional modularity of the U2 snRNP in pre-mRNA splicing ［J］. Crit Rev Biochem Mol Biol,2019,54(5):443-465.
［35］ BOELENS W,SCHERLY D,BEIJER RP,et al. A weak interaction between the U2A' protein and U2 snRNA helps to stabilize their complex with the U2B" protein ［J］. Nucleic Acids Res,1991,19(3):455-460.
［36］ REN J,WEN L,GAO X,et al. DOG 1.0:Illustrator of protein domain structures ［J］. Cell Res,2009,19(2):271-273.
［37］ BRENNAN CM,GALLOUZI IE,STEITZ JA. Protein ligands to HuR modulate its interaction with target mRNAs in vivo ［J］. J Cell Biol,2000,151(1):1-14.
［38］ WANG Y,ZHANG H,NA L,et al. ANP32A and ANP32B are key factors in the Rev-dependent CRM1 pathway for nuclear export of HIV-1 unspliced mRNA ［J］. J Biol Chem,2019,294(42):15346-15357.
［39］ PEGORARO G,MARCELLO A,MYERS MP,et al. Regulation of adeno-associated virus DNA replication by the cellular TAF-I/set complex ［J］. J Virol,2006,80(14):6855-6684.
［40］ BODEM J,SCHIED T,GABRIEL R,et al. Foamy virus nuclear RNA export is distinct from that of other retroviruses ［J］. J Virol,2011,85(5):2333-2341.
［41］ BAUER A,NEUMANN S,KARGER A,et al. ANP32B is a nuclear target of henipavirus M proteins ［J］. PLoS One,2014,9(5):e97233.
［42］ LONG JS,GIOTIS ES,MONCORGE O,et al. Species difference in ANP32A underlies influenza A virus polymerase host restriction ［J］. Nature,2016,529(7584):101-104.
［43］ STALLER E,SHEPPARD CM,NEASHAM PJ,et al. ANP32 proteins are essential for influenza virus replication in human cells ［J］. J Virol,2019,93(17):e00217-19.
［44］ LONG J S,IDOKO-AKOH A,MISTRY B,et al. Species specific differences in use of ANP32 proteins by influenza A virus ［J］. eLife,2019,8:e45066.
［45］ ZHANG H,ZHANG Z,WANG Y,et al. Fundamental contribution and host range determination of ANP32A and ANP32B in influenza a virus polymerase asctivity ［J］. Journal of Virology,2019,93(13):e00174-19.
［46］ BAKER SF,MEHLE A. ANP32B,or not to be,that is the question for influenza virus ［J］. eLife,2019,8:e48084.
［47］ GUNTHER M,BAUER A,MULLER M,et al. Interaction of host cellular factor ANP32B with matrix proteins of different paramyxoviruses ［J］. J Gen Virol,2020,101(1):44-58.
［48］ BECK S,ZICKLER M,PINHO DOS REIS V,et al. ANP32B deficiency protects mice from lethal influenza a virus challenge by dampening the host immune response ［J］. Front Immunol,2020,11:450.
［49］ CHEMNITZ J,PIEPER D,STICH L,et al. The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice ［J］. Sci Rep,2019,9(1):4853.
［50］ MUTAI H,TOYOSHIMA Y,SUN W,et al. PAL31,a novel nuclear protein,expressed in the developing brain ［J］. Biochem Biophys Res Commun,2000,274(2):427-633.
［51］ WEI MC,ZONG WX,CHENG EH,et al. Proapoptotic BAX and BAK:A requisite gateway to mitochondrial dysfunction and death ［J］. Science,2001,292(5517):727-730.
［52］ LINDSTEN T,ROSS AJ,KING A,et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues ［J］. Mol Cell,2000,6(6):1389-1399.
［53］ HUANG DC,STRASSER A. BH3-Only proteins-essential initiators of apoptotic cell death ［J］. Cell,2000,103(6):839-842.
［54］ CHIANG CW,KANIES C,KIM KW,et al. Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis ［J］. Mol Cell Biol,2003,23(18):6350-6362.
［55］ BONNI A,BRUNET A,WEST AE,et al. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and-independent mechanisms ［J］. Science,1999,286(5443):1358-1362.